Concord Biotech IPO: Listing date of the Indian Public Offering (IPO) of Concord Biotech Limited has been fixed on 18th August 2023 i.e. today. As per the BSE notice, effective from Friday, August 18, 2023, the equity shares of Concord Biotech Limited shall be listed and admitted to dealings on the exchange in the list of 'B' group of securities.
Concord Biotech IPO listing will take place in a special pre-open session at 10:00 AM. According to stock market experts, Concord Biotech shares may have a moderate debut on Dalal Street as the secondary market has been reeling under pressure for near one week. However, they maintained that much will depend upon the kind of opening Indian stock market gets on Friday.
In case of strong opening we may see Concord Biotech share price open at around ₹880 to ₹900 apiece levels whereas in case of weak opening, Concord Biotech IPO listing price could be around ₹850 to ₹860 apiece levels. Expecting moderate debut of Concord Biotech shares, Vaibhav Kaushik, Research Analyst at GCL Broking said, "We are expecting moderate debut of Concord Biotech shares on Dalal Street. The public issue received strong response from investors and primary market is also looking strong in last few months.
However, secondary market is real concern as it has been trading weak for near one week." On challenges that Concord Biotech Limited shares may have to face after listing, Anubhuti Mishra, Equity Research Analyst at Swastika Investmart said, "Concord Biotech is a leading API company with a proven track record. But its international operations expose it to various complex risks. Additionally, the industry has been facing margin pressure recently.
Read more on livemint.com